|
| 36372569 | Fragile X Syndrome Patient-Derived Neurons Developing in the Mouse Brain Show FMR1-Dependent Phenotypes. | Biol Psychiatry | 2023 |
| 34581500 | Current directions in tau research: Highlights from Tau 2020. | Alzheimers Dement | 2022 |
| 35166597 | Acute Neurotoxicity of Antisense Oligonucleotides After Intracerebroventricular Injection Into Mouse Brain Can Be Predicted from Sequence Features. | Nucleic Acid Ther | 2022 |
| 32576599 | p38<i>α</i> Regulates Expression of DUX4 in a Model of Facioscapulohumeral Muscular Dystrophy. | J Pharmacol Exp Ther | 2020 |
| 31880363 | Partial FMRP expression is sufficient to normalize neuronal hyperactivity in Fragile X neurons. | Eur J Neurosci | 2020 |
| 32092825 | Allele-Selective Knockdown of MYH7 Using Antisense Oligonucleotides. | Mol Ther Nucleic Acids | 2020 |
| 29456084 | Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene. | Cell | 2018 |
| 29806693 | Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain. | J Neurochem | 2018 |
| 28395743 | Generation of a clonal induced pluripotent stem cell (iPSC) line expressing the mutant MECP2 allele from a Rett Syndrome patient fibroblast line. | Stem Cell Res | 2017 |
| 25560755 | Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder. | Mol Psychiatry | 2015 |
| 26109678 | Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity. | J Pharmacol Exp Ther | 2015 |
| 25933020 | Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models. | PLoS One | 2015 |
| 25690789 | Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88. | Bioorg Med Chem Lett | 2015 |
| 25754495 | The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders. | Bioorg Med Chem Lett | 2015 |
| 24637750 | The structure of human tau-tubulin kinase 1 both in the apo form and in complex with an inhibitor. | Acta Crystallogr F Struct Biol Commun | 2014 |
| 25153994 | Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease. | PLoS One | 2014 |
| 23368907 | Discovery of 2-(phenoxypyridine)-3-phenylureas as small molecule P2Y1 antagonists. | J Med Chem | 2013 |
| 23809366 | Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease. | Alzheimers Dement | 2013 |
| 22024716 | The NMDA receptor co-agonists, D-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex. | Neurobiol Dis | 2012 |
| 18566482 | Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening. | J Biomol Screen | 2008 |
| 17259590 | Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assay. | J Biomol Screen | 2007 |
| 17272827 | A simple strategy for mitigating the effect of data variability on the identification of active chemotypes from high-throughput screening data. | J Biomol Screen | 2007 |
| 12946641 | An ultra-HTS process for the identification of small molecule modulators of orphan G-protein-coupled receptors. | Drug Discov Today | 2003 |
| 10891492 | Identification of B-KSR1, a novel brain-specific isoform of KSR1 that functions in neuronal signaling. | Mol Cell Biol | 2000 |
| 9858547 | Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression. | Mol Cell Biol | 1999 |
| 9572476 | Overexpression of PKCepsilon in R6 fibroblasts causes increased production of active TGFbeta. | J Cell Physiol | 1998 |
| 9371754 | KSR stimulates Raf-1 activity in a kinase-independent manner. | Proc Natl Acad Sci U S A | 1997 |
| 9000126 | PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. | Oncogene | 1996 |
| 7586146 | Altered expression of cyclins and c-fos in R6 cells that overproduce PKC epsilon. | Carcinogenesis | 1995 |
| 9815893 | Effects of suramin-related and other clinically therapeutic polyanions on protein kinase C activity. | Clin Cancer Res | 1995 |
| 7898937 | Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. | Oncogene | 1995 |
| 7767974 | Overexpression of protein kinase C beta 1 in the SW480 colon cancer cell line causes growth suppression. | Carcinogenesis | 1995 |
| 8247550 | Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. | Oncogene | 1993 |
| 8336936 | The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. | Oncogene | 1993 |
| 1887896 | Fatty acids stereospecifically stimulate neurotensin release and increase [Ca2+]i in enteric endocrine cells. | Am J Physiol | 1991 |